Irena Druce
Clinician Investigator, Inflammation & Chronic Disease
Ottawa Hospital Research Institute
Assistant Professor, Department of Medicine
University of Ottawa
Research Interests
Transgender Health
Lipid Metabolism
Diabetes
Brief Biography
Dr. Druce has a Masters of Science from the Department of Cellular and Molecular Medicine at the University of Ottawa. She completed medical school and residency trainig in Internal Medicine and Adult Endocrinology and Metabolism in Ottawa as well. She has always had a keen research interest and during her medical training participated in several projects in cardiology, pituitary disease and lipid metabolism. One of Dr. Druce's main areas of interest currently is transgender health and her hope is to contribute to clinical reasearch in this domain as her career continues.
Selected Publications
Irena Druce, Mary-Anne Doyle, Amel Arnaout, Dora Liu, Fahad AlKherayf, Charles Agbi, Erin Keely, Janine Malcolm. A Patient-Inspired Quality Improvement Initiative for Pituitary Adenoma Care.
Can J Neurol Sci. 2021 July; 48(4):540-546
Irena Druce, Hussein Abujrad, Seham Chaker, Hilary Meggison, Andrew Hill, Angela Raymond, Janice Mayne, Teik Chye Ooi. Circulating PCSK9 is lowered acutely following surgery.
J Clin Lab Anal. 2018 May; 32(4):e22358
Irena Druce, Hussein Abujrad, Teik Chye Ooi. PCSK9 and triglyceride-rich metabolism.
J Biomed Res. 2015 Jul; 29(6):429-436
Jason D Roberts, George A Wells, Michel R Le May, Marino Labinaz, Chris Glover, Michael Froeschl, Alexander Dick, Jean-Francois Marquis, Edward O'Brien, Sandro Goncalves,
Irena Druce, Alexander Stewart, Michael H Gollob, Derek Y F So. Point-of-care genetic testing for personlisation of antiplatelet treatment (RAPID GENE): a prospective, randomised, proof-of-concept trial.
Lancet. 2012 May 5; 379(9827):1705-11
Diseases, conditions and populations of interest
Research and clinical approaches
